CDEK by Data4ThePeople

Sign in Sign up

← All organizations

New York MDRU

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Dec 1, 2003

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 5 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

amantadine

Indications

Studied for

Recent trials (9)

NCT00015301CollaboratorPhase 4Dec 1, 2003
NCT00015301Overall official - principal investigatorPhase 4Dec 1, 2003
NCT00015340CollaboratorPhase 4Aug 1, 1999
NCT00015249Overall official - principal investigatorPhase 1Feb 1, 1997
NCT00015249CollaboratorPhase 1Feb 1, 1997
NCT00015288CollaboratorPhase 1Nov 1, 1996
NCT00015288Overall official - principal investigatorPhase 1Nov 1, 1996
NCT00015171CollaboratorPhase 3Apr 1, 1996
NCT00015171Overall official - principal investigatorPhase 3Apr 1, 1996

Details

Last known activity: Dec 1, 2003

Notes

New York Medications Development Research Unit (may not exist anymore- API approval dates & trial start dates prior to 2003)